| Literature DB >> 25552926 |
Yu-Rong Fu1, Kun-Shan Gao2, Rui Ji3, Zheng-Jun Yi2.
Abstract
Host-pathogen interactions determine the outcome following infection by mycobacterium tuberculosis (Mtb). Under adverse circumstances, normal Mtb can form cell-wall deficient (CWD) variants within macrophages, which have been considered an adaptive strategy for facilitating bacterial survival inside macrophages. However, the molecular mechanism by which infection of macrophages with different phenotypic Mtb elicits distinct responses of macrophages is not fully understood. To explore the molecular events triggered upon Mtb infection of macrophages, differential transcriptional responses of RAW264.7 cells infected with two forms of Mtb, CWD-Mtb and normal Mtb, were studied by microarray analysis. Some of the differentially regulated genes were confirmed by RT-qPCR in both RAW264.7 cells and primary macrophages. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was used to analyze functions of differentially expressed genes. Distinct gene expression patterns were observed between CWD-Mtb and normal Mtb group. Mapt was up-regulated, while NOS2 and IL-11 were down-regulated in CWD-Mtb infected RAW264.7 cells and primary macrophages compared with normal Mtb infected ones. Many deregulated genes were found to be related to macrophages activation, immune response, phagosome maturation, autophagy and lipid metabolism. KEGG analysis showed that the differentially expressed genes were mainly involved in MAPK signaling pathway, nitrogen metabolism, cytokine-cytokine receptor interaction and focal adhesion. Taken together, the present study showed that differential macrophage responses were induced by intracellular CWD-Mtb an normal Mtb infection, which suggested that interactions between macrophages and different phenotypic Mtb are very complex. The results provide evidence for further understanding of pathogenesis of CWD-Mtb and may help in improving strategies to eliminate intracellular CWD-Mtb.Entities:
Keywords: Mycobacterium tuberculosis; autophagy; bactericidal response; cytokine signaling; lipid metabolism.; macrophage
Mesh:
Year: 2015 PMID: 25552926 PMCID: PMC4278251 DOI: 10.7150/ijbs.10217
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Figure 1CWD-Mtb. A. Light microscopy of Mtb. H37Rv × 1000. B. Transmission electron microscopy of Mtb H37Rv. Bars = 400.00 nm. (a) CWD-Mtb; (b) normal Mtb with cell wall.
Figure 2Hierarchical clustering shows a distinguishable gene expression profiling in RAW264.7 cells among groups.
Figure 3Validation of mRNAs expression by qRT-PCR in RAW264.7 cells (A) and primary macrophages (B). Four mRNAs were randomly selected to confirm the microarray data. After normalization to endogenous control GAPDH, data were presented as mean ± SD and obtained average value for each mRNA was used for statistics. In CWD-Mtb infected RAW264.7 cells, Mapt and Lipg were increased, while NOS2 and IL-11 were decreased than those in normal Mtb infected ones (A). Our qRT-PCR results were consistent with the microarray data. Except no difference of Lipg expression, similar results of Mapt, NOS2 and IL-11 were observed in primary macrophages (B). *P < 0.05 compared with normal Mtb group.
Figure 4Production of NO by Mtb-infected RAW264.7 cells (A) and primary macrophages (B). Culture supernatants of cells infected with CWD-Mtb or normal Mtb were collected at 24 hpi and level of NO was measured using Griess reagent. Production of NO was down-regulated in CWD-Mtb infected RAW264.7 cells compared with normal Mtb infected ones (A). Similar results were also observed in primary macrophages (B). Each value indicated the mean ± SD and was representative of results obtained from 3 independent experiments. *P<0.05 vs. normal Mtb.
Figure 5KEGG pathway analysis based on down-regulated mRNAs (A) and up-regulated mRNAs (B) in CWD-Mtb group versus normal Mtb group. Enrichment Score value equals -log10 (P value). Enrichment provides a measure of the functional significance: the enrichment increases, the corresponding function becomes more specific. KEGG: Kyoto Encyclopedia of Genes and Genomes; P<0.05 were considered statistically significant.
GO process analysis based on the differentially expressed mRNAs
| BP term (up-regulated genes) | BP term (down-regulated genes) | ||
|---|---|---|---|
| ncRNA metabolic process | 1.3E-4 | MAPKKK cascade | 1.6E-5 |
| pseudouridine synthesis | 5.9E-4 | transcription | 3.2E-5 |
| ribosome biogenesis | 2.2E-3 | RNA metabolic process | 3.9E-5 |
| ncRNA processing | 2.3E-3 | cell growth | 7.5E-5 |
| translation | 7.2E-3 | regulation of biosynthetic process | 1.8E-4 |
| RNA modification | 1.0E-2 | regulation of nitrogen metabolic process | 2.4E-4 |
| rRNA processing | 1.1E-2 | regulation of cell proliferation | 2.4E-4 |
| rRNA metabolic process | 1.2E-2 | phosphorus metabolic process | 2.9E-4 |
| nucleoside monophosphate catabolic process | 1.3E-2 | chromatin organization | 3.8E-4 |
| ribonucleoprotein complex biogenesis | 1.4E-2 | regulation of cell size | 3.9E-4 |
| tRNA metabolic process | 1.5E-2 | regulation of cell death | 1.7E-3 |
| central nervous system projection neuron axonogenesis | 2.3E-2 | T cell homeostasis | 4.2E-3 |
| acute-phase response | 2.9E-2 | cytoskeleton organization | 4.6E-3 |
| ruffle organization | 3.1E-2 | regulation of membrane potential | 7.6E-3 |
| respiratory system process | 4.4E-2 | regulation of metal ion transport | 9.4E-3 |
| neurotransmitter transport | 4.4E-2 | regulation of lipid biosynthetic process | 1.0E-2 |
| negative regulation of T cell activation | 1.5E-2 | ||
| negative regulation of leukocyte activation | 1.7E-2 | ||
| regulation of apoptosis | 3.2E-2 | ||
| B cell lineage commitment | 3.5E-2 | ||
| negative regulation of defense response | 3.7E-2 | ||
| negative regulation of immune system process | 4.8E-2 | ||
| cell migration | 4.8E-2 | ||
| membrane invagination | 4.9E-2 | ||
| endocytosis | 4.9E-2 |
BP: biological process; up-regulated genes: CWD-Mtb compared to normal Mtb; down-regulated genes: CWD-Mtb compared to normal Mtb.
GO Function analysis based on the differentially expressed mRNAs.
| MF term (up-regulated genes) | MF term (down-regulated genes) | ||
|---|---|---|---|
| cytokine activity | 6.0E-4 | DNA binding | 1.3E-4 |
| pseudouridine synthase activity | 3.6E-3 | transcription factor binding | 4.0E-4 |
| 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1.2E-2 | transcription regulator activity | 4.2E-4 |
| neurotransmitter binding | 2.6E-2 | transcription activator activity | 5.7E-4 |
| neurotransmitter receptor activity | 2.6E-2 | enzyme binding | 7.4E-4 |
| receptor inhibitor activity | 2.9E-2 | cytoskeletal protein binding | 1.2E-3 |
| organic acid:sodium symporter activity | 3.4E-2 | enzyme activator activity | 2.6E-3 |
| interleukin-1 receptor binding | 3.5E-2 | protein kinase binding | 5.2E-3 |
| N-acyltransferase activity | 3.6E-2 | chromatin binding | 1.0E-2 |
| acetylglucosaminyltransferase activity | 4.2E-2 | protein dimerization activity | 1.1E-2 |
| intramolecular transferase activity | 4.5E-2 | GTPase activator activity | 1.1E-2 |
| solute:sodium symporter activity | 4.6E-2 | protein homodimerization activity | 1.2E-2 |
| transcription factor activity | 1.5E-2 | ||
| adrenoceptor activity | 1.6E-2 | ||
| kinase binding | 1.9E-2 | ||
| protein kinase activity | 2.1E-2 | ||
| zinc ion binding | 2.4E-2 | ||
| nucleotide binding | 3.1E-2 | ||
| protein serine/threonine kinase activity | 3.2E-2 | ||
| phosphoprotein phosphatase activity | 3.4E-2 | ||
| structural constituent of cytoskeleton | 3.5E-2 | ||
| RNA binding | 3.5E-2 | ||
| activin receptor activity | 3.6E-2 | ||
| growth factor activity | 3.6E-2 | ||
| phosphatase regulator activity | 4.0E-2 | ||
| lipase activity | 4.2E-2 | ||
| ligand-dependent nuclear receptor transcription coactivator activity | 4.2E-2 | ||
| protein heterodimerization activity | 4.6E-2 |
MF: molecular function; up-regulated genes: CWD-Mtb compared to normal Mtb; down-regulated genes: CWD-Mtb compared to normal Mtb.
GO Component analysis based on the differentially expressed mRNAs.
| CC term (up-regulated genes) | CC term (down-regulated genes) | ||
|---|---|---|---|
| nucleolus | 5.8E-3 | cytoskeleton | 1.2E-4 |
| extracellular space | 6.9E-3 | adherens junction | 9.3E-4 |
| nuclear lumen | 9.4E-3 | plasma membrane | 2.0E-3 |
| endoplasmic reticulum | 9.5E-3 | intracellular non-membrane-bounded organelle | 2.1E-3 |
| non-membrane-bounded organelle | 2.0E-2 | non-membrane-bounded organelle | 2.1E-3 |
| intracellular non-membrane-bounded organelle | 2.0E-2 | contractile fiber part | 2.7E-3 |
| membrane-enclosed lumen | 2.6E-2 | cytoskeletal part | 3.1E-3 |
| nucleoplasm part | 2.7E-2 | cell projection | 3.2E-3 |
| intracellular organelle lumen | 2.8E-2 | dendrite | 3.7E-3 |
| nucleoplasm | 2.8E-2 | anchoring junction | 4.4E-3 |
| organelle lumen | 2.9E-2 | chromosome | 5.0E-3 |
| contractile fiber | 6.4E-3 | ||
| chromatin | 7.8E-3 | ||
| myofibril | 1.1E-2 | ||
| nucleosome | 1.5E-2 | ||
| membrane-bounded vesicle | 1.5E-2 | ||
| protein-DNA complex | 1.9E-2 | ||
| cell projection part | 2.1E-2 | ||
| cytoplasmic membrane-bounded vesicle | 3.0E-2 | ||
| secretory granule | 3.2E-2 | ||
| nuclear periphery | 3.3E-2 | ||
| cell-substrate adherens junction | 3.6E-2 | ||
| endomembrane system | 4.1E-2 | ||
| cell junction | 4.6E-2 |
CC: cellular component; up-regulated genes: CWD-Mtb compared to normal Mtb; down-regulated genes: CWD-Mtb compared to normal Mtb.